Mpox immune test validated during Rwandan outbreak

An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting. The test, an IgG ELISA assay, is described in a new paper published in Lancet Infectious Diseases. Developed by a team from the University of Birmingham in collaboration with the Rwanda Biomedical Centre (RBC) and the University of Rwanda, the highly accurate test for mpox antibodies was successfully trialed within the National Reference Laboratory in Kigali, Rwanda.